Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.32%
1,077.09
-14.42
-1.32%
—1,091.511,090.401,090.401,074.89——
SIXC
Communications
SIXC
Communications
SIXC
-0.34%
608.06
-2.05
-0.34%
—610.11610.11610.29606.17——
SIXE
Energy
SIXE
Energy
SIXE
+0.64%
1,245.95
+7.97
+0.64%
—1,237.981,237.831,252.411,225.03——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.79%
1,731.00
-13.71
-0.79%
—1,744.711,740.951,747.291,721.57——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
636.47
-3.71
-0.58%
—640.18639.92643.19634.73——
SIXR
Staples
SIXR
Staples
SIXR
-0.85%
842.34
-7.24
-0.85%
—849.58845.27851.68841.14——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.63%
216.12
-1.36
-0.63%
—217.48217.48218.16215.79——
SIXT
Technology
SIXT
Technology
SIXT
+0.24%
3,268.41
+7.72
+0.24%
—3,260.693,273.363,287.813,240.78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.60%
936.83
-5.62
-0.60%
—942.45939.39948.80934.04——
SIXV
Health care
SIXV
Health care
SIXV
-0.34%
1,461.74
-5.06
-0.34%
—1,466.801,464.701,467.191,458.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.58%
2,383.48
-14.02
-0.58%
—2,397.502,395.032,412.012,370.64——
4568:TYO
Daiichi Sankyo Co Ltd
¥2,616.50
+1.08%
(+28.00) 1D
May 1, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4568...
Open
¥2,597
High
¥2,650
Low
¥2,568
Mkt. cap
4.96T
Avg. vol.
8.66M
Volume
7.94M
Dividend
2.64%
Quarterly dividend
¥17
P/E ratio
15.99
52-wk high
¥4,178
52-wk low
¥2,463
EPS
¥164
Shares outstanding
647.77M
No. of employees
20K
News stories
From sources across the web
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey. Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries. Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees19.8K
FoundedSep 28, 2005
HeadquartersChuo City, Tokyo, Japan
Sector-
Websitedaiichisankyo.co.jp
Next call in 7 days
Mon, May 11, 5:00 AM
Fiscal Period
Q4 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
-/ (588.52B est.)JPY
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
518.69B
474.60B
500.76B
558.11B
Cost of goods sold
94.34B
92.35B
155.98B
118.28B
Cost of revenue
94.34B
92.35B
155.98B
118.28B
Research and development expenses
133.32B
105.95B
111.72B
122.11B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
208.21B
180.35B
189.08B
228.23B
Operating expense
360.74B
285.54B
297.25B
350.29B
Total operating expenses
455.08B
377.88B
453.23B
468.57B
Operating income
63.61B
96.71B
47.52B
89.54B
Other non operating income
6.04B
-1.00M
-
-
EBT including unusual items
80.63B
105.44B
57.78B
106.73B
EBT excluding unusual items
65.04B
105.44B
57.78B
106.73B
Income tax expense
-6.52B
19.94B
12.46B
20.10B
Effective tax rate
-8.09%
18.91%
21.57%
18.83%
Other operating expenses
19.21B
-760.00M
-3.56B
-49.00M
Net income
87.15B
85.50B
45.31B
86.63B
Net profit margin
16.80%
18.02%
9.05%
15.52%
Earnings per share
-
-
-
-
Interest and investment income
2.65B
9.78B
10.68B
19.08B
Interest expense
-4.45B
-1.42B
-834.00M
-2.16B
Net interest expenses
-1.80B
8.36B
9.84B
16.91B
Depreciation and amortization charges
-
-
-
-
EBITDA
81.59B
114.51B
66.41B
109.18B
Gain or loss from assets sale
3.85B
199.00M
1.75B
573.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer